IMVT
Immunovant Inc
Price:  
14.25 
USD
Volume:  
1,329,036.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IMVT WACC - Weighted Average Cost of Capital

The WACC of Immunovant Inc (IMVT) is 10.4%.

The Cost of Equity of Immunovant Inc (IMVT) is 15.85%.
The Cost of Debt of Immunovant Inc (IMVT) is 5.00%.

Range Selected
Cost of equity 13.60% - 18.10% 15.85%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 5.00% - 5.00% 5.00%
WACC 9.3% - 11.6% 10.4%
WACC

IMVT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2.12 2.37
Additional risk adjustments 0.0% 0.5%
Cost of equity 13.60% 18.10%
Tax rate 0.10% 0.20%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 9.3% 11.6%
Selected WACC 10.4%